| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.25 | 2e-07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |